Bioanalysis encompasses the absolute and reproducible quantification of drugs and their metabolites as well as biomarkers in a biological matrix (e.g. plasma, urine, saliva,...)
Computational approaches enable prediction of individualised dosing and elucidation of underlying mechanisms relating to pharmacokinetics, efficacy and toxicity
In vitro models of liver, lung, kidney, intestine, breast and brain support determination of drug-specific PK parameters from the drug discovery stage onwards.
...identifies the specific objectives and drives the project flow.
...for cost-efficient and sustainable quality management.
...to draw the best possible conclusions.
...to meet regulatory guidelines.
...of bioanalysis and PMX to turn data into actionable insights.
...to always select the best possible team and solution.